期刊文献+

我院2009-2010年抗菌药物使用与细菌耐药性分析 被引量:15

Utilization of Antibacterial Agents and Analysis of Drug Resistance in Our Hospital during 2009-2010
原文传递
导出
摘要 目的:了解我院近2年抗菌药物使用情况及病原菌耐药性变化,探讨抗菌药物用量与细菌耐药性变迁间的相关性,指导临床合理用药。方法:采用收集、统计、对比分析方法,对我院2009-2010年临床各类标本培养分离出的病原菌分布、构成和耐药性及临床常用抗菌药物用药频度(DDDs)进行回顾性分析。结果:2年共分离出1977株病原菌,其中革兰阴性杆菌占67.98%,革兰阳性球菌占31.21%,真菌占0.81%;分离率位于前5位的病原菌分别是大肠埃希菌、表皮葡萄球菌、肺炎克雷伯菌、金黄色葡萄球菌、铜绿假单胞菌;DDDs排名前20位的抗菌药物中有12种DDDs增长,尤以头孢西丁和头孢他啶的DDDs增长迅速;多重耐药菌株分离率及耐药率也以不同程度逐年上升。结论:随着第3代头孢菌素和头霉素类药的大量使用,我院细菌耐药率逐年上升,需加强临床抗菌药物分级使用管理和细菌耐药性监测。 OBJECTIVE: To realize the change of the drug resistance and the application of antibacterial agents in recent 2 years, to discuss the relativity of the amount of antibacterial agents and the change of drug resistance in our hospital, and to guide the rational drug use in the clinic. METHODS : We collected the distribution, constitution and drug resistance of the pathogenic bac- teria which were isolated and cultivated from the clinical samples and the DDDs of the commonly used antibacterial agents in the clinic from 2009 to 2010 were analyzed retrospectively and comparatively. RESULTS: We isolated 1 977 strains of pathogenic bacte- ria for two years, Gram-negative bacilli was 67.98% of all; Gram-positive coccus was 31.21% of all; the fung was 0.81% of all. Top 5 pathogenic bacteria were Escherichia coli, Staphylococcus epidermidis, Klebsiella pneumoniae, Staphylococcus aureus and Pseudomonas aeruginosa, DDDs of 12 kinds of antibacterial agents increased among the top 20 ones, especially the DDDs of cefox- itin and ceflazidime; the separation of the multiple drug-resistant strains and the drug resistance rate ascended in varying degrees year by year. CONCLUSION: With the large amount of the third generation cephalosporin and the cephamycins used, the drug resistance rate of bacteria is increasing yearly in our hospital. We need enhance the management of the clinical antibacterial drugs in grading application and monitoring of drug resistance.
作者 董懿珍
出处 《中国药房》 CAS CSCD 2012年第10期905-907,共3页 China Pharmacy
关键词 病原菌 抗菌药物 耐药性 药敏分析 用药频度 用药管理 Pathogenic bacteria Antibacterial agents Drug resistance Drug sensitivity analysis DDDs Management of drug use
  • 相关文献

参考文献3

二级参考文献14

  • 1Bush K, Jacoby GA, Medeiros AA. A functional classification scheme for β -lactamase and its correlation with molecular structure [J ]. Antimicrob Agent Chemother, 1995,39:1211-1233.
  • 2Philip E,Coudron,Ellen S,et al. Occurrence and detection of AmpC beta-lactamase among Escherichia coli ,Klebdella pneumoniae, and Proteus mirabilis isolates at a Veterans Medical Center[J]. J Clin Microbiol, 2000,38 : 1791-1796.
  • 3Nadjar D, Labia R, Cerceau C, et al. Molecular characterization of chromosomal class C beta-lactamase and its regulatory gene in Ochrobactrton anthropl[J].Antimicrob Agents Chemother, 2001,45 (8) : 2324-2330.
  • 4Preston KE, Radomski CC, Venezia RA. Nncleotide sequence of the chromosomal AmpC gene of Enterobacter aerogenes [J]. Antimicrob Agents Chemother, 2000, 44(11) : 3158-3162.
  • 5Winokur PL,Brueggemann A,Desalvo DL, etal. Animal and human multidrug-resistant, cephalosporin-resistant Salmonella isolates expressing a plasmid-mediated CMY-2 AmpC beta-lactamase[J]. Antimicrob Agents Chemother,2000,44(10) :2777-2783.
  • 6Bradford PA, Urban C, Mariano N, etal. Imipenem resistance in Klebsiella pneunwniae is associated with the combination of ACT-1, a plasmid-mediated AmpC β -lactamase and the loss of an outer memberance protein[J]. Antimicrob Agent Chemother, 1997,41 : 563-569.
  • 7Perilli M, Dell' Amico E, Segatore B, et al. Molecular characterization of extended-spectrum β -lactamases produced by nosocomial isolates of Enterobacteriaceae from an Italian nationwide survey[J]. J Clin Microbiol,2002,40(2) : 611-614.
  • 8Thomson KS. Controversies about extended-spectrum and AmpC beta-lactamases [J ]. Emerg Infect Dis, 2001,7 (2)333-336.
  • 9Coque T,Oliver A,Perez J,et aL Genese encoding TEM-4,SHV-2, CTX-M-10 extended spectrum β -lactamases are carried by multiple Klebsiella pneurnoniae clones in a single hospital[J]. Antimicrob Agents Chemother, 2002, 46 (2) :500-510.
  • 10Afzal-Shah M, Woodford M, Livermore DM.Characterization of OXA-25, OXA-26, and OXA-27,molecular class D beta-lactamases associated with carbapenem resistance in clinical isolates of Pseudomnas aeruginosa [J ]. Antimicrob Agents Chemother, 2001,45(2) :583-588.

共引文献64

同被引文献117

引证文献15

二级引证文献61

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部